Life Sciences Virtual Event

The life sciences and biopharma space is rapidly evolving with generative AI driving innovation and attracting billions in investment dollars. Technology has accelerated clinical trials and drug discovery, leading to more personalized medicine and better patient care. But challenges in governance, access to new therapies and ethical innovation remain. Join experts in the field as they debate the future of life sciences and outlook for medtech, pharmaceuticals and more during the Becker's Life Sciences Virtual Event.

Chris Adams
Chief Executive Officer
Andarix Pharmaceuticals

Ronald C. Carter
Director, Emerging Markets
Indivior

Matthias Kleinz
Executive Vice President - Head of Life Science Investments
UPMC Enterprises

Manoja Lecamwasam
System Vice President, Intellectual Property, Life Sciences and MedDevice Strategic Innovation
CommonSpirit Health

Scott Megill
President and Chief Executive Officer
Coriell Life Sciences

Terry Myerson
Chief Executive Officer and Co-Founder
Truveta

Mohammed Quadri
Vice President of Strategy, Academics, Research and Innovation
Hackensack Meridian Health

Marva Williams-Lowe
Chief Pharmacy Officer
Medical University of South Carolina Health